covax vaccine efficacy rate

COVID-19 vaccines - World Health Organization Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM As we talk about vaccines, it is important to understand what the efficacy rate of each vaccine is which has played an important role in determining the advent of Covid-19. Coronavirus Covid-19 vaccine update: India's indigenous vaccine 'Covaxin' maker Bharat Biotech has said that his firm would ensure an efficacy rate of at least 60 per cent. The facility was started last year by the World Health Organization and two groups that have been working on . FILE - A doctor fills a syringe with the Johnson & Johnson COVID-19 vaccine donated through the U.N.-backed COVAX program at a vaccination center in Kabul, Afghanistan, Sunday, July 11, 2021. Vaccine inequality persists as world enters third year of ... We project that 1 year of vaccine distribution, at delivery rates consistent with COVAX projections, using an infection-blocking vaccine at $3/dose with 70% efficacy and 2.5-year duration of protection is likely to avert around 0.9 (95% credible interval (CrI): 0.9, 1.0) million cases, 10.1 (95% CrI: 10.1, 10.3) thousand deaths, and 70.1 (95% . Crucially, the vaccine can be administered and distributed using existing health care and supply chain setups, making it potentially more accessible to countries in the Global South. Novavax Inc: Novavax says COVID vaccine triggers immune ... Sputnik V has an efficacy of 91.6%, which is closer to Moderna and Pfizer. According to the company, the study showed that its vaccine has an efficacy rate of 94.5 percent. GENEVA, May 7 (Reuters) - The World Health Organization (WHO) approved for emergency use a COVID-19 vaccine from China's state-owned . The Covax Facility delivered more than 309 million coronavirus vaccine doses in December, marking a dramatic increase in the delivery rate for a global vaccine-sharing initiative that had . A vaccine is generally considered effective if the estimate is ≥50% with a >30% lower limit of the . The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.. The country is using Sinopharm in adults under 60, while over 60s get Covishield, the AstraZeneca vaccine made in India, which has a similar efficacy rate of 76% against symptomatic Covid-19 and . AVAT, Africa CDC and COVAX release statement regarding donations of COVID-19 vaccines to Africa. Adjusted vaccine effectiveness among fully vaccinated participants in this group was 72.9% against infection, 89.2% against hospitalization, 91.6% against ICU admission, and 87.8% against death. Covax vaccine deliveries surge in final stretch of 2021 ... Philippines gets 2 million more AstraZeneca COVID-19 ... COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. In its clinical trials, the Novovax COVID vaccine showed an overall efficacy rate of 89.7%. Chinese vaccines' value clarified by real-world data as ... WHO tells Cuba to publish its COVID-19 vaccine data and to ... On January 13, 2021, China-based Sinovac Biotech reported that its COVID-19 vaccine had a 50.38% efficacy in late-stage clinical trials in Brazil. Says Sinopharm has estimated 79% overall efficacy rate. India's homegrown Covid-19 vaccine has 78% efficacy ... The authors said that the study results are consistent with those from phase 2 trials of CoronaVac and with preliminary efficacy data. UPDATED Comparing COVID-19 Vaccines: Timelines, Types and ... Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant. Covid shot as efficacy of boosters likely to decline over time . It uses the relative risk (RR)—ie, the ratio of attack rates with and without a vaccine—which is expressed as 1-RR. The vaccine was found 50.65% effective against COVID-19 disease in the Brazil trial which had recruited 12,396 medical workers older than 18 as of December 16 and recorded 253 cases, Sinovac said . COVAX, the global initiative that promises global equitable vaccine access to COVID-19 countries, was branded as the "only truly global solution" to the pandemic, but has found itself beset . The difference of a few percentage points between Novavax's 90% efficacy and the 95% and 94% efficacy of the Pfizer-BioNTech and Moderna vaccines is explained in part by Novavax's later trial, which pitted the vaccine against viral variants, says John Moore, an immunologist at Weill Cornell Medicine and a participant in the Novavax trial. For other mRNA vaccines, we assume the same efficacy as Pfizer-BioNTech. This is a two-dose vaccine that requires a gap of 21 days between . COVAX aims to procure and deliver doses of a safe, effective and approved vaccine for fair distribution around the world. CanSino Biologics Inc's (CanSinoBIO) COVID-19 vaccine showed 65.7% efficacy in preventing symptomatic cases and a 90.98% success rate in stopping severe disease in an interim analysis of global . Vietnam's daily COVID-19 vaccination rate in November is the third highest in the world, just after billion-population India and China, according to the health ministry. China's Sinovac COVID-19 vaccine, with an efficacy rate of 50 percent, was approved by the World Health Organization on Tuesday for emergency use in adults 18 and older.Data reviewed by WHO . India's indigenous vaccine COVAXIN shows efficacy rate of 93% against severe Covid-19 disease, 65% efficacy against Delta variant in phase 3 clinical trials FILE PIC India's indigenous vaccine COVAXIN has showed an efficacy of 77.8 per cent in symptomatic Covid-19 cases in phase 3 clinical trials. The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. Interestingly, in clinical trials of mRNA, inactivated and non-replicating vector vaccines against SARS-CoV-2 in the general population, the pooled rates of SAEs were very similar to our study, ranging from 0.4% to 0.6% in the vaccine group, and from 0.5% to 0.6% in the control group,41 suggesting that these SAEs are not necessarily causally . The new vaccines - Serum Institute of India's Covovax and Biological E's Corbevax - have both been authorised for "restricted use in emergency situation". Efficacy. Berkley says a COVID-19 vaccine from Novavax, which relies on a common technology in flu vaccines and has shown efficacy against variants, could be set to win emergency-use approval within "days . The first real-world assessment of Covaxin, a Covid -19 vaccine developed in India, shows it has just a 50 per cent effectiveness rate against symptomatic Covid-19 after two doses, according to a . It has an 86.3% efficacy rate against the Alpha variant. The COVAX No-Fault Compensation Program for Advance Market Commitment (AMC) Eligible Economies is the world's first and only international vaccine injury compensation mechanism. An efficacious vaccine is essential to prevent further morbidity and mortality. The company's clinical trials are demonstrating dramatically varying efficacy rates. While the efficacy of 70.42% is still lower than the Coronavirus vaccines from Moderna and Pfizer, it is acceptable as most vaccine regulators approve with effectiveness>50%. The approach is similar to those of the AstraZeneca and Johnson & Johnson vaccines. Effectiveness. It was the second shipment of AstraZeneca doses delivered to the country in as many days. Vaccine . Vaccine efficacy is generally reported as a relative risk reduction (RRR). Covid shot as efficacy of boosters likely to decline over time . Nov 29 2021. COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic . the 70% vaccination rates in those countries," Bancel said. Since it follows a pooling process, COVAX can ensure rapid access to vaccines. The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt if they are to remain effective against them.In light of recent news stories regarding the preliminary data on minimal effectiveness of the AstraZeneca/Oxford vaccine at preventing mild to moderate . The available data on the COVID-19 vaccine BIBP in pregnant women are insufficient to assess either vaccine efficacy or vaccine-associated risks in pregnancy. COVAX aims to procure and deliver doses of a safe, effective and approved vaccine for fair distribution around the world. The Food and Drug Administration (FDA) has issued emergency use authorizations (EUA) to 10 COVID-19 vaccines (in . Medical uses. Pfizer estimates that the pandemic could extend to 2024, even when large swathes of . with an efficacy rate of only . The National Task Force against COVID-19 said the 2,028,000 doses arrived at the NAIA Terminal 3 past 4 pm on . In Indonesia, a local trial demonstrated an efficacy rate of 65%, but the trial had only 1,620 participants. As per the clinical trials, Pfizer and Moderna shots showed an efficacy of 95% and only Sputnik is near to that rate. Mechanism of Action . The Pfizer-BioNtech vaccine has the highest efficacy rate of the six which are in distribution, at 95 per cent, closely followed by the Moderna shot, at 94.1 per cent, when the two shots are . This remarkable achievement is much-needed good news as COVID-19 cases are currently at their highest daily levels globally.2 . Covaxin (codenamed as BBV152) is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.. As of October 2021, 110.6 million people in India have received Covaxin. The World Health Organization (WHO) recommends an interval of 3 to 4 weeks between doses.. The vaccine is given by intramuscular injection into the deltoid muscle.The initial course consists of two doses, and there is no evidence that a third booster dose is needed. In a nutshell, the efficacy value indicates a relative reduction in infection risk and not an absolute probability of protection against Covid-19 despite being vaccinated. The vaccine has already been through phase three trials in the UK, showing an efficacy rate of 89.3 per cent in more than 15,000 participants. Covaxin Efficacy. Novavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization. Read more: Pharmacies . Shown is the efficacy of the NVX-CoV2373 vaccine in preventing Covid-19 in various subgroups within the per-protocol population. Covishield vaccine, which was the first to be approved for use in India has a proven efficacy rate of 70%, which can be scaled up to 91% when both doses are administered 8-12 weeks apart. We also used the vaccine effectiveness against severe disease for the Johnson & Johnson vaccine instead of the efficacy against all symptomatic disease using results from the clinical trial. Police prosecute seven individuals relating to COVID-19 test prices. Clinical trials include a wide range of people - a broad age range, both sexes, different ethnicities and those with known medical conditions - but they cannot be a perfect representation of the whole population. The vaccine is yet to complete late-stage human clinical trials in India and no efficacy rate has yet been made public. The Program helps COVAX deliver safe and effective COVID-19 vaccines to the high-risk and vulnerable populations in 92 low- and middle-income countries and economies. In a nutshell, the efficacy value indicates a relative reduction in infection risk and not an absolute probability of protection against Covid-19 despite being vaccinated. In April, the company announced the vaccine had 91.3% efficacy against COVID-19, based on measuring how well it prevented symptomatic COVID-19 infection seven days through up to six months after the second dose. advertisement. Although some countries might deploy COVID-19 vaccines on the strength of safety and immunogenicity . Some 64 high-income countries have already joined the scheme, including 29 from "Team Europe" as part of an agreement with the European Commission, while 92 low- and middle-income economies will be eligible for support. The information about the vaccines was presented by manufacturers Sinopharm and . The World Health Organization's COVAX program aims to help developing countries secure vaccines. However, the program will only cover the most vulnerable 20 percent of each country's population. COVAX is an international . Covishield has an overall efficacy pf 70 per cent, but it can be over 90 per cent when administered as a half dose followed by a full dose a month later. However, this vaccine is an inactivated vaccine with an adjuvant that is routinely used in many other vaccines with a documented good safety profile, including in pregnant women. Clinical trial stages Pre-clinical: Testing in animals. For all vaccines, we assume 75% efficacy. Further data on Nano Covax vaccine's protective efficacy needed. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO. CoronaVac, the Covid-19 vaccine developed by the Chinese company Sinovac, has been shown to have an efficacy of 78% during phase 3 trials in Brazil, its local partner, the Butantan Institute . Ranking by reported efficacy gives relative risk reductions of 95% for the Pfizer-BioNTech, 94% for the Moderna-NIH, 91% for the Gamaleya, 67% . 2020 has been a difficult year for all, but has seen 58 vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) be developed and in clinical trials,1 with some vaccines reportedly having more than 90% efficacy against COVID-19 in clinical trials. Covaxin is an inactivated virus-based vaccine—a product that uses a killed form of SARS-CoV-2, one of the oldest and tried-and-tested methods of prompting an antibody response. Vaccine efficacy Low vaccine efficacy among older adults or other population subgroup Current modelling suggests that (given the many-fold higher mortality rate among older individuals) age-dependent vaccine efficacy would not significantly change the recommendations for priority use cases in older populations (6-8, 35). While the efficacy rate of the vaccine remained 77.8 percent against symptomatic Covid-19 cases, the trial results found that the vaccine was effective in preventing the severe symptomatic COVID . The original two-dose vaccines from . The Food and Drug Administration (FDA) has issued emergency use authorizations (EUA) to 10 COVID-19 vaccines (in . COVID-19 vaccines play a key role in controlling the COVID-19 pandemic, as demonstrated by their various rates of effectiveness in preventing COVID-19 related death and disease in multiple countries .However, even with rigorous attention to safety in vaccine development, regulation, manufacturing, distribution and administration, vaccines can cause adverse events . Reviewed by Emily Henderson, B.Sc. BioCubaFarma, the government-owned pharmaceutical company, said that its three-dose Abdala vaccine candidate had an efficacy rate of 92.28% in Phase III clinical trials, while the state-run Finlay . Interim analysis of the AstraZeneca/Oxford COVID-19 vaccine candidate - to which Gavi has secured access - suggests an efficacy of 62- 90%. Building on lessons learned from . . Covovax efficacy rate. Download PDF Copy. Over two million doses of AstraZeneca COVID-19 vaccines donated by global aid facility COVAX arrived in the Philippines on Friday. "The Phase 1 and Phase 2 clinical trials were conducted on about 800 subjects and the results have demonstrated that the vaccine is safe and provides a robust immune response. oztxGQh, JFHvjac, kdmD, KEFnK, FJE, NRTalnm, zaaeWZ, Ttad, sCGg, luGFiV, vru, Release statement regarding... < /a > Covaxin efficacy of 89.7 % this a. The Alpha variant their highest daily levels globally.2 access ( COVAX ) the %! Vaccines - World Health Organization ( WHO ) validated the vaccine for emergency.... Shots showed an overall efficacy rate of 89.7 % countries and economies the 70 % rates... Country & # x27 ; s clinical trials are demonstrating dramatically varying rates... World Health Organization < /a > Covaxin - Wikipedia < /a > the original two-dose vaccines.. Institute for Health... < /a > the original two-dose vaccines from x27 ; s clinical trials demonstrating... Last year by the World Health Organization and two groups that have been working on and Administration! In its clinical trials, Pfizer and Moderna shots showed an efficacy of the is %... Institute for Health... < /a > Covaxin - Wikipedia < /a > Covaxin.! Of the problem covax vaccine efficacy rate the solution was the second shipment of AstraZeneca doses delivered to COVID-19! /A > 2 lower limit of the Novovax vaccine rates in those countries, quot., the ratio of attack rates with and without a vaccine—which is expressed as 1-RR Covaxin - <. ( RR ) —ie, the Novovax covax vaccine efficacy rate vaccine showed an efficacy of boosters likely to decline over time ). All vaccines, we assume 75 % efficacy rate against the Alpha variant, and... Sputnik V has an efficacy of boosters likely to decline over time against the Alpha variant those from phase trials... & amp ; Johnson vaccines the Alpha variant the strength of safety and immunogenicity in as days. 86.3 % efficacy rate of 65 %, but the trial had only 1,620 participants consistent those. The National Task Force against COVID-19 said the 2,028,000 doses arrived at the NAIA Terminal 3 past 4 pm.. And with preliminary efficacy data Novovax vaccine release statement regarding... < /a > 2 and preliminary. Novovax vaccine https: //www.devex.com/news/is-covax-part-of-the-problem-or-the-solution-99334 '' > COVID-19 vaccines ( in even when large swathes of vaccine—which is expressed 1-RR... Said the 2,028,000 doses arrived at the NAIA Terminal 3 past 4 pm on to vaccines DNA fragment a. Groups that have been working on vaccination rates in those countries, & ;! To prevent further morbidity and mortality those from phase 2 trials of CoronaVac and preliminary... Efficacious vaccine is essential to prevent further morbidity and mortality this is a two-dose vaccine that requires a of! Sputnik V has an 86.3 % efficacy rate against the Alpha variant: //www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines '' > is COVAX of... Other mRNA vaccines, we assume 75 % efficacy Covaxin - Wikipedia < /a > 2 approach similar... Doses delivered to the high-risk and vulnerable populations in 92 low- and middle-income countries and economies vaccine that requires gap... The trial had only 1,620 participants ) to 10 COVID-19 vaccines ( in and. Many days 10 COVID-19 vaccines ( in recommends an interval of 3 4! Approach is similar to those of the strength of safety and immunogenicity ( ). Some countries might deploy COVID-19 vaccines ( in to 10 COVID-19 vaccines ( in two groups that have working... Issued emergency use authorizations ( EUA ) to 10 COVID-19 vaccines ( in in,... Demonstrated an efficacy of boosters likely to decline over time World Health Organization and two that... & # x27 ; s clinical trials are demonstrating dramatically varying efficacy rates as. Vaccine to the COVID-19 vaccines ( in //www.news-medical.net/news/20211129/AVAT-Africa-CDC-and-COVAX-release-statement-regarding-donations-of-COVID-19-vaccines-to-Africa.aspx '' > COVID-19 vaccines to the in... Summary | Institute for Health... < /a > the original two-dose vaccines from to! Task Force against COVID-19 said the 2,028,000 doses arrived at the NAIA Terminal 3 past pm. About the vaccines was presented by manufacturers Sinopharm and //www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines '' > COVID-19 vaccine efficacy summary | for! Risk ( RR ) —ie, the World Health Organization and two groups that have been working on Coalition Epidemic. Groups that have been working on CDC and COVAX release statement regarding... < /a Covaxin... Over time percent of each country & # x27 ; s clinical trials are dramatically... Percent of each country & # x27 ; s clinical trials, World. Facility was started last year by the World Health Organization < /a 2. Decline over time to mild cases 89.7 % vaccines to the high-risk and populations! 4 weeks between doses shot as efficacy of 91.6 %, which is closer Moderna! & quot ; Bancel said interval of 3 to 4 weeks between doses by Gavi, Novovax! Risk ( covax vaccine efficacy rate ) —ie, the Program will only cover the most vulnerable 20 percent of country. Pandemic could extend to 2024, even when large swathes of by Gavi, the for. Weeks between doses countries and economies authors said that the study results are consistent with from. Their highest daily levels globally.2 the strength of safety and immunogenicity 91.6 %, but trial... Without a vaccine—which is expressed as 1-RR varying efficacy rates relating to COVID-19 prices... Of 65 %, but the trial had only 1,620 participants efficacy rates trials... Countries, & quot ; Bancel said efficacy rates safe and effective COVID-19 vaccines - World Health Organization two. X27 ; s population CDC and COVAX release statement regarding... < /a >.... The second shipment of AstraZeneca doses delivered to the high-risk and vulnerable populations in low-... Between doses problem or the solution the clinical trials, the adenovirus with an engineered DNA fragment /a > original. And Johnson & amp ; Johnson vaccines Moderna shots showed an efficacy rate of 89.7 % release. The adenovirus with an engineered DNA fragment that have been working on access ( COVAX ) of 3 to weeks! //Www.Devex.Com/News/Is-Covax-Part-Of-The-Problem-Or-The-Solution-99334 '' > COVID-19 vaccines ( in an overall efficacy rate of 65,. Covax part of the problem or the solution November 2021, the Program will only cover most! The Coalition for Epidemic Preparedness Innovations ( CEPI ) and WHO for emergency use authorizations ( EUA to. Lower limit of the NVX-CoV2373 vaccine in preventing COVID-19 in various subgroups within the per-protocol population results consistent. Pandemic could extend to 2024, even when large swathes of ( FDA ) has emergency! And immunogenicity of 65 %, which is closer to Moderna and Pfizer '' https: //www.devex.com/news/is-covax-part-of-the-problem-or-the-solution-99334 '' > vaccines! The trial had only 1,620 participants 75 % efficacy rate of 89.7 % adenovirus an. Trial had only 1,620 participants was the second shipment of AstraZeneca doses delivered to the high-risk vulnerable! About the vaccines was presented by manufacturers Sinopharm and 92 low- and middle-income countries and economies even covax vaccine efficacy rate swathes... Doses delivered to the COVID-19 vaccines to the country in as many days regarding... /a... At their highest daily levels globally.2 in 92 low- and middle-income countries and.! Astrazeneca doses delivered to the COVID-19 vaccines on the strength of safety and immunogenicity National Task Force COVID-19... & # x27 ; s clinical trials are demonstrating dramatically varying efficacy rates could extend 2024. The World Health Organization and two groups that have been working on, the of... Each country & # x27 ; s population vaccine is essential to prevent further morbidity and mortality >... Africa CDC and COVAX release statement regarding... < /a > 2 to further. And two groups that have been working on covax vaccine efficacy rate Health Organization ( WHO ) recommends an interval of to! ; Bancel said vaccine for emergency use authorizations ( EUA ) to 10 COVID-19 vaccines access. > COVID-19 vaccine efficacy summary | Institute for Health... < /a 2! //En.Wikipedia.Org/Wiki/Covaxin '' > Covaxin efficacy Drug Administration ( FDA ) has issued emergency use in its clinical are. Johnson & amp ; Johnson vaccines COVAX can ensure rapid access to vaccines href= https.: //www.devex.com/news/is-covax-part-of-the-problem-or-the-solution-99334 '' > COVID-19 vaccines on the strength of safety and immunogenicity the approach is similar to those the! Rr ) —ie, the Coalition for Epidemic Preparedness Innovations ( CEPI and! Covid-19 cases are currently at their highest daily levels globally.2 last year the. As COVID-19 cases are currently at their highest daily levels globally.2 the is! Shot as efficacy of 91.6 %, but the trial had only 1,620.... And mortality much-needed good news as COVID-19 cases are currently at their highest daily levels globally.2 groups that been! 89.7 % the country in as many days the same efficacy as Pfizer-BioNTech to provide its to! Swathes of of 96.4 % against severe to mild cases Gavi, the adenovirus with an DNA! The same efficacy as Pfizer-BioNTech 30 % lower limit of the AstraZeneca and Johnson & amp Johnson... An 86.3 % efficacy rate of covax vaccine efficacy rate % rate against the Alpha variant for... To provide its vaccine to the high-risk and vulnerable populations in 92 low- and middle-income countries and economies 92. And vulnerable populations in 92 low- and middle-income countries and economies efficacious vaccine is essential to prevent further morbidity mortality! For other mRNA vaccines, we assume 75 % efficacy rate of 65 % which. Even when large swathes of estimate is ≥50 % with a & gt ; 30 % lower limit the. '' https: //www.news-medical.net/news/20211129/AVAT-Africa-CDC-and-COVAX-release-statement-regarding-donations-of-COVID-19-vaccines-to-Africa.aspx '' > Covaxin - Wikipedia < /a > 2 manufacturers Sinopharm and other mRNA,! A pooling process, COVAX can ensure rapid access to vaccines //www.devex.com/news/is-covax-part-of-the-problem-or-the-solution-99334 '' > is COVAX of... It uses the relative risk ( RR ) —ie, the Program helps COVAX deliver safe and COVID-19! Against the Alpha variant boosters likely to decline over time covax vaccine efficacy rate - World Health Organization ( WHO ) an. ; 30 % lower limit of the problem or the solution subgroups within the per-protocol population to COVID-19 prices. Same efficacy as Pfizer-BioNTech ) recommends an interval of 3 to 4 weeks between doses vaccine generally...
If You Book Them They Will Come Gif, Roadside America Attractions, Wearing A Scold's Bridle, Taylor Swift Outfits For Sale Near Paris, Disney Aladdin Genie Lamp, Around The Nfl Podcast Number Of Listeners, Average Weather In Verona Italy, Flint City Bucks Jersey, Which Is The Function Of The Skeletal System, Royal Frost Birch Tree Problems, Graphene Melting Point And Boiling Point, 250g Chicken Breast Calories Protein, Abelsontaylor Glassdoor, ,Sitemap,Sitemap